Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – Commentary

  • John R Corboy
  • Multiple Sclerosis Journal, July 2017, SAGE Publications
  • DOI: 10.1177/1352458517717809

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1177/1352458517717809